Answers are grounded in this paper and cite their sources.
Real-world data reveals early-onset adverse events in EGFR-mutated non-small cell lung cancer, indicating a need for toxicty mitigation strategies.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Le et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: